Dataset,Inclusion Criteria,Study Type,Total No. Participants Included,Mean (SD) No. Visits,Mean (SD) Months Followed,Mean (SD) ALSFRS-R Slope
PRO-ACT,>= 4 visits,Clinical Trial,2814,10 (4),12.18 (6.24),-1.05 (0.87)
CEFT,>= 4 visits,Clinical Trial,453,10 (5),19.79 (10.35),-1.15 (0.71)
PRO-ACT,>= 10 visits,Clinical Trial,1327,14 (3),15.55 (6.70),-0.89 (0.65)
CEFT,>= 10 visits,Clinical Trial,228,14 (4),26.91 (9.21),-0.81 (0.43)
